시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 OTC 검사 시장 보고서(2025년)
Over The Counter Test Global Market Report 2025
상품코드 : 1730977
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,212,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 8,980,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,747,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

OTC 검사 시장 규모는 향후 수년간 급성장이 예상될 예정입니다. 예측 기간 동안의 성장은 전염병 유병률 증가, HIV 감염자 수 증가, 원격 환자 모니터링 사용 증가, 스마트폰 보급률 증가, 의료 관련 감염(HAI) 증가와 같은 요인에 기인할 수 있습니다.

만성 질환의 유병률 증가는 OTC 검사 시장의 성장을 가속할 것으로 예측됩니다. 건강에 해로운 생활 습관, 식생활의 혼란, 운동 부족, 고령화 등의 요인이 심장병, 당뇨병, 비만 등의 만성 질환의 유병률 상승에 기여하고 있습니다. 상태를 모니터링하고 잠재적인 문제를 조기에 발견하고 필요에 따라 치료 계획을 조정할 수 있기 때문에 만성 질환 관리에 필수적입니다. 예를 들어, 2024년 6월 호주 보건 복지 연구소는 만성 질환으로 인한 사망률이 2021년 인구 10만 명당 459명에서 2022년 10만 명당 490명으로 증가했다고 보고했습니다.

OTC 검사 시장의 기업은 자기 모니터링의 정확성, 편리성, 질병의 조기 발견을 향상시키기 위해 혁신적인 비침습적 가정내 진단제의 개발에 주력하고 있습니다. 바이오센서, 타액 또는 소변 검사, 웨어러블 디바이스, 이미지 툴 등의 기술은 바이탈 사인의 측정, 질병의 검출, 만성 상태의 모니터링을 집에서 실시하기 위해 사용됩니다. 예를 들어, 2023년 12월, 미국에 본사를 둔 분자 진단 회사인 DiaCarta는 미국 FDA 510(k) 승인을 받은 가정에서 사용할 수 있는 OTC 분변 잠혈 검사(FOBT)인 iColon 테스트를 출시했습니다. 이 비침습적인 검사는 위장장애나 대장암의 중요한 지표인 편잠혈을, 집에 있으면서 검출할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

An over-the-counter test is a self-diagnostic medical test that individuals can buy without a prescription for personal use. It enables users to detect or monitor health conditions at home without the need for professional supervision. These tests offer quick and convenient results, supporting early detection and effective health management.

The primary product types of over-the-counter tests include glucose monitoring tests, pregnancy and fertility tests, coagulation monitoring tests, urinalysis tests, cholesterol tests, and other diagnostic tests. Glucose monitoring tests are devices used to measure blood sugar levels, helping individuals with diabetes track and manage their glucose levels. The technologies used in these tests include immunoassays, lateral flow assays, and dipsticks. These tests are utilized in various fields such as cardiology, oncology, glucose monitoring, pregnancy and fertility, infectious diseases, and toxicology, and are used by end-users such as hospitals, clinics, home care settings, diagnostic laboratories, and other healthcare facilities.

The over the counter test market research report is one of a series of new reports from The Business Research Company that provides over the counter test market statistics, including the over the counter test industry global market size, regional shares, competitors with the over the counter test market share, detailed over the counter test market segments, market trends, and opportunities, and any further data you may need to thrive in the over the counter test industry. This over the counter test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The over the counter test market size has grown rapidly in recent years. It will grow from $23.79 billion in 2024 to $27.20 billion in 2025 at a compound annual growth rate (CAGR) of 14.3%. The growth during the historic period can be attributed to factors such as the rise of smart home healthcare, increased remote patient monitoring, the growth of outpatient clinics, the expansion of mHealth (mobile health) solutions, and the growing popularity of subscription-based services.

The over the counter test market size is expected to see rapid growth in the next few years. It will grow to $46.11 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth during the forecast period can be attributed to factors such as the increasing prevalence of infectious diseases, a rising number of HIV-infected individuals, greater use of remote patient monitoring, the growing penetration of smartphones, and the rise in healthcare-associated infections (HAIs). Key trends in the forecast period include the integration of digital health, connectivity with mobile apps, the adoption of integrated care models, the use of AI and machine learning, and remote infection control monitoring.

The increasing prevalence of chronic diseases is expected to drive the growth of the over-the-counter (OTC) test market. Chronic diseases are long-lasting conditions that persist for a year or more, often requiring continuous medical care or restricting daily activities. Factors such as unhealthy lifestyles, poor dietary habits, physical inactivity, and an aging population contribute to the rising prevalence of chronic conditions such as heart disease, diabetes, and obesity. OTC tests are vital for managing chronic diseases as they enable individuals to monitor their health regularly, detect potential issues early, and adjust treatment plans as necessary. For example, in June 2024, the Australian Institute of Health and Welfare reported that the death rate due to chronic conditions rose from 459 per 100,000 population in 2021 to 490 per 100,000 in 2022. This increasing prevalence of chronic diseases is driving the growth of the OTC test market.

Companies in the OTC test market are focusing on developing innovative non-invasive at-home diagnostics to improve accuracy, convenience, and early disease detection for self-monitoring. These diagnostics include medical tests and monitoring devices that enable individuals to assess their health conditions without invasive procedures. Technologies such as biosensors, saliva or urine tests, wearable devices, and imaging tools are used to measure vital signs, detect diseases, and monitor chronic conditions at home. For instance, in December 2023, DiaCarta Inc., a US-based molecular diagnostics company, launched the iColon test, an OTC at-home Fecal Occult Blood Test (FOBT) that received US FDA 510(k) clearance. This non-invasive test allows individuals to detect blood in their stool, a critical indicator of gastrointestinal disorders and colorectal cancer, in the comfort of their homes. The iColon test aims to improve early disease detection and encourage proactive health monitoring, leading to better patient outcomes.

In October 2024, Abhay HealthTech Private Limited, an India-based healthcare and technology company, acquired MNP Healthcare Private Limited for an undisclosed amount. This acquisition is intended to strengthen Abhay HealthTech's presence in the OTC healthcare segment by expanding its product range, manufacturing capabilities, and distribution network. MNP Healthcare is an India-based pharmaceutical company specializing in the production of blood glucose test kits.

Major players in the over the counter test market are Johnson & Johnson, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Viatris Inc., Roche Diagnostics Corporation, Hologic Inc., Nipro Diagnostics Inc., Quidel Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Everlywell Inc., LetsGetChecked Inc., OraSure Technologies Inc., Ellume Health Ltd., Bionime Corporation, ACON Laboratories Inc., Wondfo Biotech Co. Ltd., and Geratherm Medical AG.

North America was the largest region in the over-the-counter test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in over the counter test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the over the counter test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The over the counter test market consists of revenues earned by entities by providing services such as mobile app integration, subscription services, and follow-up lab testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The over the counter test market also includes sales of self-diagnostic medical test kits, home testing devices, rapid screening kits, point-of-care diagnostic tests, and at-home health monitoring kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Over The Counter Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on over the counter test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for over the counter test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The over the counter test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Over The Counter Test Market Characteristics

3. Over The Counter Test Market Trends And Strategies

4. Over The Counter Test Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Over The Counter Test Growth Analysis And Strategic Analysis Framework

6. Over The Counter Test Market Segmentation

7. Over The Counter Test Market Regional And Country Analysis

8. Asia-Pacific Over The Counter Test Market

9. China Over The Counter Test Market

10. India Over The Counter Test Market

11. Japan Over The Counter Test Market

12. Australia Over The Counter Test Market

13. Indonesia Over The Counter Test Market

14. South Korea Over The Counter Test Market

15. Western Europe Over The Counter Test Market

16. UK Over The Counter Test Market

17. Germany Over The Counter Test Market

18. France Over The Counter Test Market

19. Italy Over The Counter Test Market

20. Spain Over The Counter Test Market

21. Eastern Europe Over The Counter Test Market

22. Russia Over The Counter Test Market

23. North America Over The Counter Test Market

24. USA Over The Counter Test Market

25. Canada Over The Counter Test Market

26. South America Over The Counter Test Market

27. Brazil Over The Counter Test Market

28. Middle East Over The Counter Test Market

29. Africa Over The Counter Test Market

30. Over The Counter Test Market Competitive Landscape And Company Profiles

31. Over The Counter Test Market Other Major And Innovative Companies

32. Global Over The Counter Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Over The Counter Test Market

34. Recent Developments In The Over The Counter Test Market

35. Over The Counter Test Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기